Literature DB >> 8225187

Growth hormone and prolactin variants in normal subjects. Relative proportions in morning and afternoon samples.

M D Warner1, Y N Sinha, C A Peabody.   

Abstract

There are multiple molecular forms of both growth hormone (GH) and prolactin (PRL). Traditionally the two hormones have been measured by radioimmunoassay (RIA) techniques. Recently, several molecular variants of these hormones have been discovered using Western blotting techniques: four GH size variants, 27K GH, 22K GH (the classical form), 20K GH (an alternatively-spliced form), and 17K GH, and two PRL structural variants, a glycosylated (G-PRL) and a nonglycosylated form. In this study, we measured these GH and PRL variants in 18 normal subjects in the morning in a fasting state and in the afternoon in a non-fasting state. Contrary to expectations, the predominant serum GH form in both morning and afternoon samples was found to be 17K, not 22K GH, accounting for 82-89% of the total circulating GH. The predominant serum PRL form was found to be the nonglycosylated variant, constituting 83-84% of the total circulating PRL. None of the GH or PRL variants were significantly different when comparing morning to afternoon samples. These results provide, for the first time, evidence for the existence of two new GH-immunoreactive components in human sera, the 17K and 27K GH, the former in proportions often higher than those of the classical 22K GH, and argue for the need to measure them individually.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225187     DOI: 10.1055/s-2007-1002137

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma.

Authors:  R Guido; S Valenti; L Foppiani; D De Martini; M Cossu; M Giusti
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

2.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Authors:  I Struman; F Bentzien; H Lee; V Mainfroid; G D'Angelo; V Goffin; R I Weiner; J A Martial
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

3.  Development of Vasoinhibin-Specific Monoclonal Antibodies.

Authors:  Nils Müller; Juan Pablo Robles; Magdalena Zamora; Johannes Ebnet; Hülya Markl-Hahn; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch; Jakob Triebel
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-20       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.